Nature’s Sunshine Products (NASDAQ:NATR) Releases Earnings Results, Beats Expectations By $0.10 EPS

Nature’s Sunshine Products (NASDAQ:NATR) issued its quarterly earnings results on Thursday. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.10, FiscalAI reports. The firm had revenue of $122.89 million for the quarter, compared to analyst estimates of $122.15 million. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.74%.

Here are the key takeaways from Nature’s Sunshine Products’ conference call:

• Nature’s Sunshine reported a strong Q1 with $122.9 million in net sales (up 9% YoY), GAAP net income of $5.1 million ($0.28/share), and adjusted EBITDA up 33% to $14.6 million.
• Digital momentum is a primary growth driver: North America digital sales rose 42% YoY, new digital customers increased 60%, and autoship subscriptions now represent 48% of website sales, improving retention and lifetime value.
• Regional performance was broad-based: APAC grew 7% (China +40% in Q1 but management cautioned this pace is unlikely to repeat), Japan/Korea benefited from a skincare launch, and Europe grew 9% aided by better product availability despite Ukraine-related risks.
• Gross margin improved 116 basis points to 73.2% (management expects ~73% average for 2026) driven by logistics, manufacturing efficiency, sourcing and pricing actions, while the balance sheet shows $87.6 million in cash and zero debt.
• The company reiterated 2026 guidance of $500–515 million in sales and $50–54 million in adjusted EBITDA while planning measured technology and go-to-market investments (CTO hire, ERP/AI work, consultant app) that will temper near-term EBITDA growth but aim to support a long-term vision to reach $1 billion in sales and a 15% EBITDA margin.

Nature’s Sunshine Products Trading Down 1.3%

NATR stock traded down $0.32 during mid-day trading on Friday, reaching $24.23. The company’s stock had a trading volume of 137,584 shares, compared to its average volume of 69,771. The stock has a market cap of $424.27 million, a PE ratio of 22.03 and a beta of 0.95. Nature’s Sunshine Products has a fifty-two week low of $12.97 and a fifty-two week high of $28.14. The company’s 50 day moving average is $25.65 and its two-hundred day moving average is $22.97.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on NATR. Canaccord Genuity Group set a $37.00 price target on shares of Nature’s Sunshine Products in a research note on Friday. Weiss Ratings raised shares of Nature’s Sunshine Products from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 20th. Finally, DA Davidson upped their target price on shares of Nature’s Sunshine Products from $23.00 to $33.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Nature’s Sunshine Products currently has an average rating of “Buy” and a consensus price target of $35.00.

Nature’s Sunshine Products News Summary

Here are the key news stories impacting Nature’s Sunshine Products this week:

• Positive Sentiment: Nature’s Sunshine reported Q1 revenue of $122.9 million, topping expectations and rising sharply year over year, while adjusted/GAAP EPS also beat estimates. Nature’s Sunshine Products Q1 earnings report
• Positive Sentiment: The company said it is targeting $1 billion in sales and a 15% EBITDA margin longer term, which signals management confidence in future growth and profitability. Nature’s Sunshine sales and EBITDA target article
• Neutral Sentiment: Shareholders approved the 2026 stock incentive plan at the annual meeting, a routine governance item that may help align employees with long-term performance. Shareholders approve 2026 stock incentive plan
• Neutral Sentiment: Management reiterated full-year 2026 revenue guidance of $500 million to $515 million, which was broadly in line with expectations rather than a major upside surprise. Nature’s Sunshine Q1 2026 results press release
• Negative Sentiment: Despite higher sales, gross profit and operating profit fell sharply year over year, and operating cash flow was negative, raising questions about margin durability and cash generation. Nature’s Sunshine Q1 2026 earnings reaction article
• Negative Sentiment: Insider selling has been heavier than buying over the past six months, which can temper enthusiasm even after a solid quarter. Nature’s Sunshine insider trading activity

Insider Buying and Selling at Nature’s Sunshine Products

In other news, EVP Daniel C. Norman sold 15,383 shares of the business’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $24.52, for a total transaction of $377,191.16. Following the transaction, the executive vice president owned 55,693 shares of the company’s stock, valued at approximately $1,365,592.36. The trade was a 21.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Bryant J. Yates sold 19,516 shares of the business’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $24.35, for a total transaction of $475,214.60. Following the transaction, the executive vice president directly owned 85,154 shares in the company, valued at approximately $2,073,499.90. The trade was a 18.65% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 38,899 shares of company stock worth $951,206. Insiders own 3.10% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of Nature’s Sunshine Products by 2.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 913,791 shares of the company’s stock valued at $14,181,000 after acquiring an additional 20,037 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Nature’s Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock valued at $12,464,000 after acquiring an additional 106,688 shares during the last quarter. Kennedy Capital Management LLC boosted its position in shares of Nature’s Sunshine Products by 14.6% during the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock valued at $10,488,000 after acquiring an additional 86,128 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Nature’s Sunshine Products by 3.3% during the 4th quarter. Renaissance Technologies LLC now owns 524,097 shares of the company’s stock valued at $11,310,000 after acquiring an additional 16,900 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Nature’s Sunshine Products by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 360,546 shares of the company’s stock valued at $7,782,000 after acquiring an additional 1,980 shares during the last quarter. Institutional investors and hedge funds own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.